US 11524081
Codon optimized REP1 genes and uses thereof
granted A61KA61K48/005A61K48/0058
Quick answer
US patent 11524081 (Codon optimized REP1 genes and uses thereof) held by 4D MOLECULAR THERAPEUTICS INC. expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- 4D MOLECULAR THERAPEUTICS INC.
- Grant date
- Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K48/005, A61K48/0058, A61K48/0066, A61K48/0075